SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-006524
Filing Date
2013-01-31
Accepted
2013-01-31 17:04:11
Documents
7
Period of Report
2013-01-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-4066_18k.htm 8-K 87266
2 EX-10.1 a13-4066_1ex10d1.htm EX-10.1 248009
3 EX-10.2 a13-4066_1ex10d2.htm EX-10.2 45615
4 EX-10.3 a13-4066_1ex10d3.htm EX-10.3 35227
5 EX-10.4 a13-4066_1ex10d4.htm EX-10.4 44143
6 EX-10.5 a13-4066_1ex10d5.htm EX-10.5 35254
7 EX-99.1 a13-4066_1ex99d1.htm EX-99.1 95495
  Complete submission text file 0001104659-13-006524.txt   592405
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-23731 | Film No.: 13563383
SIC: 2833 Medicinal Chemicals & Botanical Products